Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Jianmin Pharmaceutical Group CoSHSE:600976 -1.02%59 Days Inventory is 92.27 as of Mar. 2026, which is 104% above its 10-year median of 45.32. GuruFocus rates SHSE:600976 with a GF Score™ of 59/100 and a GF Value™ of ¥41.74 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 922 Drug Manufacturers companies, Jianmin Pharmaceutical Group Co ranks better than 85.25% on this metric.
The historical rank and industry rank for Jianmin Pharmaceutical Group Co's Days Inventory or its related term are showing as below:
SHSE:600976'
s Days Inventory Range Over the Past 10 Years
Min: 33.99 Med: 45.32 Max: 83.92
Current: 83.92
During the past 13 years, Jianmin Pharmaceutical Group Co's highest Days Inventory was 83.92. The lowest was 33.99. And the median was 45.32.
SHSE:600976's Days Inventory is ranked better than 85.25% of 922
companies
in the Drug Manufacturers industry
Industry Median: 164.58
vs SHSE:600976: 83.92
Inventory Turnover measures how fast the company turns over its inventory within a year.
Jianmin Pharmaceutical Group Co's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.99.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Jianmin Pharmaceutical Group Co's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.35.
Jianmin Pharmaceutical Group Co (SHSE:600976) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Jianmin Pharmaceutical Group Co's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Jianmin Pharmaceutical Group Co's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Jianmin Pharmaceutical Group Co Days Inventory Related Terms
Jianmin Pharmaceutical Group Co Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jianmin Pharmaceutical Group Co Days Inventory Chart
SHSE:600976 vs ZTS, UTHR: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Jianmin Pharmaceutical Group Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jianmin Pharmaceutical Group Co Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Jianmin Pharmaceutical Group Co's Days Inventory distribution charts can be found below:
* The bar in red indicates where Jianmin Pharmaceutical Group Co's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jianmin Pharmaceutical Group Co (SHSE:600976) has a Days Inventory of 92.27 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Jianmin Pharmaceutical Group Co and its competitors. This is 104% above median its historical median of 45.32. Over the past decade, Jianmin Pharmaceutical Group Co's Days Inventory has ranged from 33.99 to 83.92. According to the industry distribution chart, Jianmin Pharmaceutical Group Co ranks #136 out of 922 companies in the Drug Manufacturers industry, placing it in the top 14.8%.
Is Jianmin Pharmaceutical Group Co's Days Inventory too high?
Jianmin Pharmaceutical Group Co's current Days Inventory of 92.27 is 104% above median its 10-year median of 45.32. Over the past 10 years, this metric has ranged from a low of 33.99 to a high of 83.92. The Drug Manufacturers industry median Days Inventory is 164.58. Jianmin Pharmaceutical Group Co's value of 92.27 is 43.9% below this industry median. Based on the distribution chart, Jianmin Pharmaceutical Group Co ranks #136 out of 922 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Jianmin Pharmaceutical Group Co has a GF Score™ of 59/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Jianmin Pharmaceutical Group Co's Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Jianmin Pharmaceutical Group Co ranks #136 out of 922 companies for Days Inventory. This places Jianmin Pharmaceutical Group Co in the top 15% of its industry — outperforming the majority of peers. The industry median Days Inventory is 164.58. Jianmin Pharmaceutical Group Co's value of 92.27 is 43.9% below this benchmark. Historically, Jianmin Pharmaceutical Group Co's own Days Inventory has ranged from 33.99 to 83.92 over the past decade. While the company's 10-year median is 45.32 vs. the industry median of 164.58, Jianmin Pharmaceutical Group Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.58, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jianmin Pharmaceutical Group Co's current Days Inventory of 92.27 is 43.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Jianmin Pharmaceutical Group Co and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.58 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jianmin Pharmaceutical Group Co's current Days Inventory is 92.27, which is 104% above median its own 10-year median of 45.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jianmin Pharmaceutical Group Co stock overvalued right now?
Based on GuruFocus' analysis, Jianmin Pharmaceutical Group Co (SHSE:600976) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥41.74, compared to a current price of ¥29.12 — trading 30.2% below its estimated fair value. The current Days Inventory is 92.27, which is 104% above median its 10-year median of 45.32 and 43.9% below the Drug Manufacturers industry median of 164.58. Jianmin Pharmaceutical Group Co's overall GF Score™ is 59/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Jianmin Pharmaceutical Group Co (SHSE:600976), the current Days Inventory is 92.27 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jianmin Pharmaceutical Group Co (SHSE:600976) Overvalued in 2026?
Based on GuruFocus' analysis, Jianmin Pharmaceutical Group Co stock appears to be undervalued.
The current stock price of ¥29.12 is trading 30.2% below its estimated GF Value™ of ¥41.74.
GuruFocus considers Jianmin Pharmaceutical Group Co to be Significantly Undervalued.
Key valuation signals for SHSE:600976:
Days Inventory: 92.27 (104% above median its 10-year median of 45.32)
GF Value™: ¥41.74 vs. price of ¥29.12 (30.2% below fair value)
Industry Position: 43.9% below the Drug Manufacturers median (#136 of 922)
No single metric tells the full story. See the SHSE:600976 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jianmin Pharmaceutical Group Co Business Description
Jianmin Pharmaceutical Group Co Ltd is engaged in the manufacture and distribution of pharmaceutical products. It adheres to the core position of pediatric medicine, gynecological medicine, and special Chinese medicine, it offers products under Jianmin and Longmu brands.
59GF Score
Get the complete analysis for SHSE:600976
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600976 has been successfully added to your 
